estivation 1 . Such strategies serve as a bridge to sustain the animal through a period 66 of deprivation to a time of greater nutrient abundance. Cave---dwelling animals, in 67 particular, must withstand long periods of nutrient limitation, as caves lack 68 photosynthesis---driven primary producers, and hence cave food chains are 69 dependent on energy input from external sources, such as seasonal floods or bat 70 droppings 2 . To thrive under such harsh and unpredictable conditions, cave animals 71 must evolve unique metabolic strategies that are currently not well understood. 72
The Mexican Tetra, Astyanax mexicanus, is a particularly useful model to 73 study the genetic basis of metabolic adaptation. This species consists of a river---74 dwelling (surface) population and multiple cave---dwelling (cave) populations (Fig. 75 1a) that experience dramatically different nutrient availablility. In this study, we 76 focused on three cavefish populations (named for the caves they inhabit: Tinaja, 77
Pachón, and Molino) that have evolved independently from two different stocks of 78 surface fish that invaded caves millions of years ago 3 . Tinaja and Pachón cavefish 79 likely originated from a more ancient surface population than the Molino 80 population 4 . More importantly, the surface morphs and all cave morphs are inter---81 fertile, allowing for genetic studies both in the wild and under laboratory 82 conditions 5,6,7 . 83
We have previously shown that cavefish are starvation resistant compared to 84 surface fish and lose a smaller fraction of their bodyweight after two months 85 without food 8 . Several factors have been identified that contribute to starvation 86 resistance, including a reduction in metabolic circadian rhythm 9 , a general decrease 87 in the metabolic rate 10 , and elevated body fat levels that serve as an energy dense 88 reserve 8, 11 . However, the genetic changes underlying these extreme metabolic 89 adaptations remain largely unknown. 90 A critical aspect of metabolic homeostasis is the regulation of blood 91 glucose 12 . We compared the blood glucose levels of lab---raised surface fish with lab---92 raised cavefish (Tinaja, Pachón, Molino) and found that one hour after eating, all 93 three cave populations had significantly higher blood glucose (63, 76, 92 vs 94 51mg/dL respectively, Fig. 1b ). We further investigated the dynamics of glucose 95 homeostasis during fasting by comparing surface and Tinaja populations. While 96 Tinaja cavefish had significantly higher blood glucose levels after 24 hours of fasting 97 (60 vs 52mg/dL, p=0.05, Fig. 1b ), they were unable to maintain glucose homeostasis 98 long---term, reaching as low as 22mg/dL after 21 days without food (mean 26mg/dL, 99 Fig. 1c ). In contrast, surface fish blood glucose did not change significantly over the 100 same fasting period (52 vs. 45 mg/dL, p=0.49). Our findings suggest that surface fish 101 have tighter control of blood glucose levels. 102
To further test this hypothesis, we compared the acute control of glucose 103 homeostasis using a glucose tolerance test (Fig. 1d ). We injected glucose into the 104 intraperitoneal (IP) cavity of both surface fish and Tinaja cavefish, transiently 105 raising blood glucose levels to over 400 mg/dL in most fish ( Fig. 1d ). After eight 106 hours, the blood glucose levels of the surface fish returned to the same levels as the 107 PBS---injected controls (mean 126 vs 120mg/dL, Fig. 1d ), while blood glucose levels 108 remained highly elevated in Tinaja cavefish, (mean 374mg/dL, p<0.0005, Fig. 1d ). 109
Tinaja cavefish blood glucose levels decreased over time, but remained elevated 110 compared to surface at both 14hrs (158 vs. 38mg/dL, p<0.05, Fig. 1d ) and 24hrs (85 111 vs. 51mg/dL, p<0.005, Fig. 1d ) after glucose injection. These results suggest that 112 cavefish have impaired glucose clearance. 113
Glucose homeostasis requires the balanced release of the hormones insulin 114 and glucagon that signal to peripheral tissues to absorb glucose from the blood or 115 produce glucose from stored glycogen 13 . We compared the levels and actions of 116 these hormones between surface and Tinaja fish to gain further insight into their 117 differences in glucose regulation. We did not detect a difference in the number of 118 cells producing glucagon (54 vs 50, p=0.678) or insulin (54 vs 52, p=0.275) in 10---119 day old fish, (n=5 fish per population, Extended Data Fig. 1 ) and similarly we did not 120 detect a difference in circulating glucagon levels in adult fish (Extended Data Fig. 2 ). 121
Circulating insulin levels tended to be higher in Tinaja cavefish, but the results were 122 not significant (n=24 fish per population, 2 age groups, and 3 samples per fish, 123 Extended Data Fig. 3 ). Nonetheless, we found evidence of diminished insulin 124 response in cavefish: we injected arginine into surface fish and cavefish to stimulate 125 the simultaneous release of glucagon and insulin 14 and observed that while surface 126 fish had a significant decrease in blood glucose level (80 vs 38mg/dL, p=0.006), 127 Tinaja, Pachón, and Molino blood glucose did not change (Fig. 1e ). In addition, we 128 found that injection of recombinant human insulin caused a significant drop in 129 blood glucose after 60 minutes in Surface fish but not in Tinaja cavefish (Extended 130 data Fig.4 ). Our combinded observations that glucagon and insulin levels do not 131 differ between surface and cavefish (Extended Data Fig. 2 ), and that cavefish do not 132 decrease blood glucose levels in repsonse to arginine or insulin (Fig, 1e , Extended 133 data Fig. 4 ) suggest that cavefish may be insulin resistant. 134
Insulin---stimulated glucose uptake proceeds through phosphorylation of AKT 135 at serine 473 (pAKT) 15 . We compared the ratio of pAKT vs AKT in freshly dissected 136 cavefish and surface fish skeletal muscle treated with recombinant insulin (Fig. 1f , 137 g). Consistent with the apparent dysregulation of glucose homeostasis, we observed 138 lower pAKT levels in the Tinaja muscle after insulin treatment (mean 1.39 vs 0.775 139 average pAKT/AKT, p=0.017, Fig. 1f , g), suggesting that Tinaja cavefish are indeed 140 insulin resistant relative to surface fish. To study if insulin resistance evolved as a 141 common feature in derived cavefish populations, we tested insulin sensitivity in 142 Pachón and Molino. Interestingly, Pachón muscle had lower pAKT levels in response 143 to insulin (mean 0.806 average pAKT/AKT, p=.027, Fig. 1f , g), but despite having 144 elevated blood glucose ( Fig. 1b ), Molino pAKT levels were equivalent to surface fish 145 (mean 1.26 average pAKT/AKT, p=0.99, Fig. 1f To gain insight into the genetic mechanism underlying the observed insulin 173 resistance in cavefish, we examined the sequences of all known genes in the insulin 174 pathway using the available genome sequence 16 (Extended data 1). Strikingly, we 175 found a coding difference in the insulin receptor gene (insra) between surface fish 176 and cavefish, affecting a highly conserved proline in the extracellular cysteine rich 177 domain (P211L, Fig.  2a ---c). The presence of the mutation correlates with the insulin 178 resistance phenotype, as both Tinaja and Pachón populations carried the mutation, 179
while Molino cavefish showed the wildtype allele ( Fig. 2b, c) . Notably, the same 180 genetic alteration is implicated in at least two known cases of Rabson---Mendenhall 181 syndrome 17,18 , a form of severe insulin resistance in humans ( Fig. 2c ). The 182 biochemical impact of the mutation has not been previously explored, but the 183 position in the cysteine---rich domain suggests a role in insulin binding 19 . To test this, 184 we generated transgenic HEK293T (Flp---In---293) cell lines that stably express the 185 full---length surface fish or Tinaja cavefish insra and incubated the cells with different 186 concenctrations of FITC---labeled human insulin. We measured fluorescence as a 187 readout for binding efficiency using an image---based cytometry approach 188 (ImagestreamX MarkII) and found that cells expressing the cavefish receptor 189 displayed significantly lower binding at all but the lowest concentrations of insulin 190 ( Fig.  2d ). Our results suggest that the insra P211L mutation affects insulin signaling 191 by altering insulin binding efficiency. with Tukey's HSD post hoc test, *p<0.05, **p<0.005, ***p<0.0005. 212 213 214
We found that two independently---derived cavefish populations (from the 215 Tinaja and Pachón caves) carry the same P211L mutation, suggesting parallel 216 molecular evolution and selection for the mutation in the cave environment 21 . To 217 extend these observations, we tested for the presence and frequency of the P211L 218 mutation in fish living in their natural habitats. We sequenced 71 wild---caught 219 surface fish samples from different localities, and 51 cavefish samples from 6 220 different caves (Extended data 2, Fig. 3a ). In line with our previous observations, the 221 mutation was absent in all the Molino samples (n=8), but present in all other tested 222 cave populations (Tinaja, Yerbaniz, Pachón, Japonés, Arroyo, combined n=36). 223
Notably, the cave populations carrying this mutation are all derived from the same 224 ancestral stock of surface fish 22 . Although the mutation was partially present in 225 heterozygote conditions in some of these caves, we did not find any cavefish that 226 were homozygous for the surface allele despite continuous gene flow from the 227 surface population 22 (Fig. 3a ). Our findings suggest the likelihood that there is active 228 selection for the mutation in the caves, and also indicate a partially dominant effect 229 of the cave allele. We did not detect the cave allele in any of the surface fish samples, 230
suggesting that the mutation either appeared de novo in the cave populations, 231 represents a rare variant not detected by our sampling frequency, or is absent in the 232 current surface population, but was present in the ancestral surface fish stocks 22 . 233
We reexamined the available whole genome data from different cave and surface 234 populations (McGaugh et al, unpublished) to investigate these hypotheses. We found 235 that insra is not exceptional in its divergence between cave and surface fish using 236 multiple independent statistical methods (FST, DXY, of hapFLK results; Extended Data 237 Our current hypothesis is that the mutation represents a rare variant in the 244 ancestral or current stock of surface fish that fell under positive selection upon 245 invasion of the caves. 246 247
We next sought to investigate the adaptive value of the mutation in the cave 248 environment. Insulin resistance can result from obesity, but conversely it can also 249 drive processes leading to adipogenesis and fat storage 24 . We found that cavefish 250 weigh more than surface fish on a nutrient limited diet (2.08 vs 1.52 grams, p=0.02, 251 Fig. 3b ), raising the intriguing possibility that the insulin resistance in cavefish is 252 part of an adaptive strategy to increase weight and thus survivability during food 253 deprivation. To test for the influence of the insra mutation on weight, we genotyped 254 and weighed 124 surface/Tinaja male F2 fish at approximately 1.5 years of age. We 255 focused on males, as egg mass varies between individual females and can account 256 for as much as 41% of female body weight (Extended Data Fig. 5 ), thus representing 257 a potentially significant confounding variable if included in our analysis. Notably, we 258 found that males carrying one or two copies of the cave P211L insra allele weigh on 259 average 27% more than hybrids carrying only the surface allele (1.63 vs 1.28 grams, 260 p = 0.006, Fig. 3c ). To test if the difference in weight is entirely attributable to 261 metabolic differences in processing ingested food or is also affected by differences 262 in consumption when fed ad libitum, we individually housed the fish and fed them a 263 controlled diet of 6 mg of food per day for 4 months. On average, both carriers and 264 non---carriers of the mutated insra allele gained weight, but no significant difference 265 was observed in percent weight gain (17.3% and 20.5%, respectively; p---value: 266 0.68), underscoring the importance of overeating in combination with insulin 267 resistance to increase body weight 8 . After four months on the controlled diet, 268 carriers of the cave allele still weighed significantly more than homozygous surface 269 carriers (1.82 vs 1.47 grams, p=0.004, Fig. 3d ). These findings indicate a role of the 270 cavefish insra locus on weight gain, but cannot entirely exclude the possibility of 271 another effect of a different gene in cis to the P211L mutation. 272
To verify that the phenotypes we have associated with the P211L mutation in 273 cave fish are indeed due to the alteration of the insra gene, we used CRISPR gene 274 editing to introduce the P211L mutation into the insra gene in zebrafish (Danio 275 rerio) via homology directed repair 25 (Supp. Figure 1, Figure 3e ). We have shown 276 that the P211L mutation causes a decrease in insulin binding (Fig. 2d ). To determine 277 if decreased binding causes insulin resistance in zebrafish, we measured the ratio of 278 pAKT/AKT in freshly dissected zebrafish skeletal muscle treated ex vivo with insulin 279 or PBS (Fig. 3f ). We found that the ratio of pAKT/AKT is less in zebrafish that are 280 homozygous for the P211L mutation compared to heterozygous fish for both PBS 281 (0.05 vs 0.13, *p=0.016) and insulin treated conditions (0.13 vs 0.32, p=0.067, n=3 282 fish per genotype and condition). We next tested whether this insulin resistence is 283 sufficient to explain the increase in weight we observe in cavefish carrying the 284 P211L mutation. We paired heterozygous fish with successful germline 285 transmission and weighed their progeny shortly before maturity (55 dpf) to avoid 286 gonadal effects on weight. We found that zebrafish homozygous for the cave allele 287 are longer (20.0 mm vs 18.4 mm, p=0.0046) and weigh more (124.6 mg vs 99.7 mg, 288 p=0.022) than their siblings raised under the same conditions ( Fig. 3e, g, h) . Thus, 289 our findings show that the P211L mutation is sufficient to explain both the insulin 290 resistance and increased weight that we observe in Tinaja cavefish. 291 292 The extreme metabolic phenotypes, reminiscent of Type 2 diabetes (insulin 327 resistance, hyperglycemia), in conjunction with the fact that cavefish have a fatty 328 liver 8 , raise the question whether cavefish have pathologies that are characteristic of 329 these phenotypes in other species and are therefore less healthy than surface fish. If 330 so, it would suggest an evolutionary trade---off wherein the cavefish might have 331 sacrificed other aspects of physiological health to reap the benefits of starvation 332 resistance. Alternatively, the fish could have evolved unique compensatory 333 mechanisms allowing them to remain healthy despite potential deleterious 334 metabolic changes. In support of the latter idea, surface fish and cavefish live longer 335 than fifteen years in the laboratory with no noticeable differences in fertility decline. 336
However, we find that surface fish begin to exhibit classic signs of aging in fish (e.g. 337 27 ) by age fifteen, such as sunken skin, tattered fins, and a hunched back (Fig 4a) 338 while Tinaja and Pachón can live in excess of fourteen years without these 339 indications of senescence (Fig. 4b.c ). 340 341 342 AGEs in the serum of two year---old cavefish and surface fish that had been fed ad 364 libitum their entire lives (Fig. 4b) . Interestingly, we did not detect any differences in 365 the levels of AGEs between Tinaja and Pachón cavefish, relative to surface fish 366 (mean of 9.7, 9.3, and 8.9 μg/ml respectively, p=0.99, 0.95 ), in spite of elevated 367 blood glucose levels in fish from these cave populations (Fig. 1b) . This result 368 suggests that these two cavefish populations may have mechanisms for reducing 369 protein glycation, rendering them impervious to the damaging effects of elevated 370 blood glucose. Notably, the Molino cavefish, which we found are not insulin resistant 371 but nonetheless show higher blood sugar levels, do have elevated levels of AGEs 372 compared to surface fish (mean 14.1 vs. 8.9 μg/ml, p=0.03). It remains to be 373 determined if the health and longevity of the Molino population is influenced by 374 accumulation of AGEs, but our results suggest they may have evolved altered blood 375 glucose homestasis through a different mechanism than Tinaja and Pachón cavefish. 376
Insulin resistance in human patients carrying the Tinaja and Pachón---specific 377 mutation in insra is accompanied by additional sequelae, including dental dysplasia, 378 and growth retardation 17 , 18 , neither of which are observed in cavefish 30 . 379
All organisms need to adapt to the environments in which they live. This 380 includes optimizing the utilization of the nutrients available to them, in addition to 381 evolving strategies for finding food and for avoiding predation. Yet far less is known 382 about metabolic adaptation than, for example, morphological evolution. Our results 383 suggest a unique, and perhaps surprising, metabolic strategy adopted by cavefish in 384 response to annual extended periods of extreme nutrient deprivation. In particular, 385 the cave morphs of Astyanax mexicanus alter blood glucose levels as a partial 386 mechanism for rapidly increasing body weight during brief periods of abundance. 387
These findings highlight the extreme physiological measures that can evolve in 388 critical, and otherwise highly conserved, metabolic pathways to accommodate 389 exceptional environmental challenges. Additionally, our findings establish cavefish 390 as a natural model to investigate resistance to pathologies of diabetes---like 391 dysregulation of glucose homestasis. As such, further understanding cavefish 392 metabolism may reveal factors that can help eliminate both short---term and long---393 term negative effects of elevated blood glucose levels in humans, as well as 394 providing further insight into the metabolic changes that can allow organisms to 395 adapt to extreme environments. 396 397
Methods 398

Fish husbandry and diet 399
Unless stated otherwise, fish were fed ad libitum with a combination of New Life 400
Spectrum TheraA+ small fish formula and Artemia, and housed at densities of less 401 than, or equal to, two adult fish per liter of water. F2 hybrids were housed 402 individually in 1.5L tanks and fed three pellets (~6mg) of New Life Spectrum 403 TheraA+ small fish formula once per day for >4 months. For the starvation 404 experiment, fish were moved to individual containers and water was changed daily. 405 406
Blood glucose, glucose tolerance, and arginine tolerance 407
Blood was collected from the caudal tail vein using a U---100 insulin needle and 408 glucose was measured using Freestyle lite blood glucose meter and test strips. 409
Glucose (2.5mg/gram fish), arginine (6.6µM/gram fish), or PBS was injected into the 410 intraperitoneal cavity using a U---100 insulin needle. 411 412
pAKT quantification 413
We quantified pAKT level in fillets of skeletal muscle taken directly after fish 414 decapitation. For A. mexicanus, skeletal muscle was cut into three equal strips per 415
fish. Strips were incubated in PBS, X, 0.1X concentration of recombinant Human 416 insulin for 25 mins (sigma product I9278, X = 9.5---11.5 µg/mL insulin). The tissues 417
were rinsed in pbs and then homogenized and lysed in RIPA buffer (SIGMA) with 418 protease and phosphatase inhibitor (Pierce™ Protease and Phosphatase Inhibitor 419
Mini Tablets, EDTA Free) for 30 mins. Protein concentration was measured via BCA 420 (Pierce). Lysate protein concentrations were then equalized and run on 4---12% Bis---421
Tris protein gel and transferred on a nitrocellose membrane. Blots were probed for 422
AKT (Cell Signalling). Following stripping, blots were probed for phospho---AKT 423 (ser473) (Cell Signalling). Densitometry was done on imageJ. For D. rerio two fillets 424 of skeletal muscle were removed from both sides of fish directly after decapitation. 425
Fillets were rinsed in PBS and then incubated in PBS or 10µg/mL human 426 recombinant insulin (sigm, I0908) for approximatley 40 minutes. The skin was then 427 removed from the skeletal muscle and the muscle was finley minced using a scalpel. 428 We quantified the ratio of pAKT/AKT using the Akt ( Glucagon and Insulin quantification 465
The number of cells producing insulin or glucagon were determined using the 466 following protocol: 10---11dpf fish were euthanized with an overdose of tricane and 467 fixed in 4% paraformaldehyde overnight at 4°C. Fish were washed in PBST, 468 transferred to water for 1 minute, acetone for 10 minutes at ---20℃, water for 1 469 minute, then washed in PBST. Blocking in 5% donkey serum, 1% DMSO, and 0.2% 470 BSA was done for 1 hour at room temperature. Fish were incubated with primary 471 antibodies (1:200 sheep anti---Glucagon (abcam), 1:200 guinea pig anti---472
Insulin (Dako)) and then secondary antibodies (1:400 donkey anti---sheep 488, 1:400 473 goat anti---guinea pig 647) overnight at room temperature in glass vials, then washed 474 with PBST, stained with DAPI, and imaged. Images were collected at 63X using a 475
1.0μm z---stack on a Zeiss 780 confocal microscope. Nuclei surrounded by insulin or 476 only glucagon were counted manually using FIJI cell counter. 477
To quantify circulating glucagon level, we collected serum from the caudal tail vein 478 of fish that were approximately 2---years---old and were fasted for 24 hours (n=12 for 479 each population). The serum was used for a Glucagon radioimmunoassay according 480 to the manufacturer protocol (MGL---32K; Millipore, Billerica, MA). To quantify 481 circulating insulin level we collected plasma from the caudal tail vein of 2---year---old 482
and 1---year---old fish and blotted the serum onto a nitrocellulose membrane using a 483 BIO---RAD Bio---dot sf device. Ponceau protein staining was used to verify equal 484 protein loading after which insulin was probed using anti---Insulin 485 (DAKO). Quantification of insulin levels was done using FIJI---imageJ. 486 487
Insulin Binding Experiment 488
The full---length Astyanax mexicanus insra protein---coding sequence was amplified 489
from Surface fish (S) and Tinaja cavefish (T) cDNA and cloned into a modified 490 pcDNA3.1/Hygro vector providing an N---terminal FLAG epitope tag 36 . To generate 491 stable cell lines, the FLAG---tagged insra cassettes were cloned into pcDNA5/FRT 492 vector (Invitrogen cat# V601020) allowing for Flp recombinase---mediated 493 integration into the Flp---In---293 cell line (Invitrogen cat# R75007) per the 494 manufacturer's procedures. One positive clone from each S and T cell line was 495 selected and used for the insulin---binding assays. 100mm plates were seeded at 30% 496 confluency and cultured in DMEM/10%FBS+1xGlx media for 48 hours. The plates 497
were then changed to insulin---free FreeStyle 293 Expression Medium (cat# 498 12338018) and incubated for an additional 24 hours. Plates at 70---80% confluency 499
were pre---chilled for 30 min at 4°C, and the medium replaced with 5 ml of cold 500
FreeStyle 293 Dye (FVD eFluor450, Invitrogen cat# 65---0863) was added to each 1mL of cell 509 suspension and incubated on ice in the dark for 20 min. Subsequently, the cells were 510
washed once with cold 1x PBS and fixed in 1mL of 4% formaldehyde. After two 511 more washes with cold 1x PBS, the cells were resuspended in 150µl of cold 1x PBS, 512
filtered through a 70µm cell strainer (Filcons 070---67---S) and transferred into a 513 round---bottom 96---well plate. Binding data was acquired on an ImagestreamX MarkII 514 (EMD Millipore) at 40x. FITC was excited with 150mW 488nm on camera 1 and 515 detected on channel 2. Fixable live/dead was excited with 12mW 405nm on camera 516 2 and detected on channel 7. Single color controls were used for color 517 compensation. Bright field was collected on channels 5 and 11. Analysis was 518 performed in IDEAS v6.2 and fluorescence intensity was reported as integrated 519
intensity within an adaptive erode mask for bright field. 520 521
Genome editing in zebrafish using the CRISPR/Cas9 technology 522
Guide---RNA and donor design 523
We designed the guideRNA target sites using the web tool by the MIT Zhang lab 524 (http://crispr.mit.edu). We then validated the target region and checked for SNPs by 525 PCR and sequencing of genomic DNA. We used Cas9 protein from PNABio and 2---part 526
Alt---R guideRNAs from IDT. Single---stranded oligodeoxynucleotides (ssODNs) were 527 ordered as Ultramers from IDT for generating the SNP mutations. The ssODNs 528
included 100bp of homology arms as well as silent mutations in the guideRNA target 529 site to prevent re---annealing of the guideRNA following homologous recombination. 530
We also protected both ends of the ssODNs with 3 phosphorothioate bonds to 531 inhibit exonuclease degradation in the cell. 532
Microinjection 533
We annealed the specific crRNA with tracrRNA to form the guideRNA complex, 534 followed by hybridizing with the Cas9 protein to form a ribonucleoprotein (RNP) 535 complex. The RNP was then injected into at least 200 and up to 1500 zebrafish 536 embryos at the 1---cell stage. 537
Screening and breeding 538
We designed genotypic screening assays to find mutants and confirm the expected 539 location of the mutation. After injections, we screened for mutation success rate in 540 the F0. We then outcrossed mosaic individuals to wildtype and tested for germline 541 transmission rates and to raise potential heterozygous mutants. 542 543
Quantification of Advanced Glycation Endproduct (AGEs) 544 We used Oxiselect™ Advanced Glycation End Product (AGE) Competitive Elisa Kit 545 (San Diego, CA) according to the manufacturers protocol to measure AGE level in 546 serum from 2---year---old fish that were fasted for 3 days. 547 548
Statistics and Figure preparation 549
Figures and statistics were produced using R 37 and ggplot2 38 package. 550 551
Data availability 552
The datasets generated during the current study are available in the Stowers 553 original data repository and/or available from the corresponding author on 554 reasonable request. 555 556 557
